Acurian
Acurian is a privately-held clinical trial patient recruitment company founded in 1998 that connects pharmaceutical sponsors and CROs with patients and physicians for participation in clinical drug trials across multiple therapy areas.
- Company typePrivate
- Founded1998
- HeadquartersHorsham, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Acurian does
Acurian is a privately-held clinical trial patient recruitment company founded in 1998 and headquartered in Horsham, Pennsylvania. According to firmographic data, the company's core function is recruiting patients and physicians for participation in clinical drug trials, operating with a workforce of 51-100 employees. The business serves pharmaceutical sponsors and contract research organizations (CROs) that require patient identification, engagement, and pre-screening services across a range of therapy areas including biosimilars, cardiovascular, dermatology, metabolic, neurology, respiratory, vaccines, and early-phase clinical trials.
The company's service offering encompasses patient identification and engagement, pre-screening, integrated site services, and home-based trial visit options. Distribution relies on direct enterprise sales engagement with sponsors and CROs, supported by a proprietary patient database used to match trial protocols with eligible participants. The patient recruitment value chain spans marketing to potential participants, screening for protocol eligibility, and retention through trial completion. Marketing channels include organic search, content marketing via insights/blog resources, and LinkedIn professional engagement targeting the sponsor and CRO buyer audience.
Acurian has raised approximately $43.4M across disclosed funding rounds spanning 1998 through 2017, with strategic pharmaceutical participation including Merck Capital Ventures across multiple rounds and EuclidSR Partners as lead in the 2001 round. The company maintains a private structure with Leslie Michelson as Chief Executive Officer and Scott Ballenger as Vice President of Business Development. Detailed pricing models, revenue figures, and named customer relationships are not publicly disclosed in the input data.
Acurian firmographics
Firmographics- Name
- Acurian
- Legal name
- Trialmed
- Website
- https://acurian.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Acurian is a privately-held clinical trial patient recruitment company founded in 1998 that connects pharmaceutical sponsors and CROs with patients and physicians for participation in clinical drug trials across multiple therapy areas.
- Ownership category
- akta.pro rank
Acurian industry classification
Industry- Product category
- Clinical Trial Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
- akta.pro secondary industries
- Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where Acurian is headquartered
LocationHeadquarters
- HQ city
- Horsham
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Acurian business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical trial site services: Trialmed operates a network of 250+ high-performing clinical trial sites and provides integrated site services including patient identification, engagement, pre-screening, and site management. Revenue is generated through study fees charged to pharmaceutical sponsors and CROs for patient recruitment, site access, and trial management services.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Acurian product offering
Product offeringCore offering
Acurian (operating as Trialmed) recruits patients and physicians for participation in clinical drug trials and delivers integrated clinical trial site services to pharmaceutical sponsors and CROs. The company operates a network of 250+ owned clinical trial sites across the US, UK, Czech Republic, and Poland, supported by a 20M+ identified patient database, and provides patient identification, engagement, pre-screening, site management, and home/remote trial visit services across multiple therapy areas.
Product overview
No Acurian-specific product information is available in the provided source data. The source data describes Trialmed, a separate clinical trials and research company offering patient recruitment, site services, and clinical trial management solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Integrated Clinical Trial Site Services
- Patient Identification and Engagement
- Pre-Screening Services
- Home Trial Services
- Early Phase Clinical Trials
- Therapy Area Specialist Trials
- Patient Study Finder Portal
Quantifiable outcome
- 250+ high-performing sites
- +3 more outcomes
Companies that use Acurian
Customer profileSegments2 records
Ideal customer profiles2 records
Acurian technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Acurian partnerships and signals
Strategic signalScale indicators5 records
Recent moves4 records
Expansion highlights3 records
Acurian competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: A dedicated site management organization (SMO) operating a large network of owned and integrated clinical trial sites across the US. Directly comparable to Trialmed's 250+ site network and integrated site services model.
- CenExel: A clinical research site network with therapeutic-area expertise (including early phase and CNS) and embedded patient recruitment capabilities. Comparable in business model as a focused SMO with patient recruitment built into site operations.
- Medpace: A mid-size full-service CRO with strong site management and patient recruitment capabilities across multiple therapy areas. Directly comparable to Trialmed as a CRO with site services and recruitment focus.
Broad incumbents
- ICON plc: A global full-service CRO that acquired PRA Health Sciences, offering broad clinical operations, site services, and patient recruitment. Comparable in customer base (pharma sponsors) and broad therapy-area coverage.
- IQVIA: The world's largest CRO with extensive site network, real-world data assets, and patient recruitment technology. Competes with Trialmed for the same pharmaceutical sponsor and CRO customers on a global scale.
- Syneos Health: A global biopharmaceutical solutions organization (now privately held) offering clinical development and commercialization services, including site management and patient recruitment. Comparable in serving the same sponsor base with full-service capabilities.
- PPD (Pharmaceutical Product Development): A global CRO now part of Thermo Fisher Scientific (the same parent as Trialmed), with extensive site and patient recruitment capabilities. Comparable as a sibling entity serving the same end markets through the same parent platform.
- Parexel: A global clinical research and biopharmaceutical services provider offering site management, patient recruitment, and full-service clinical operations. Comparable in sponsor customer base and global delivery model.
Emerging players
- Science 37: A decentralized clinical trial platform that enables remote and home-based patient participation. Comparable to Trialmed's home trial services offering and emerging as a recruitment and participation disruptor.
- Deep 6 AI: An AI-driven patient recruitment platform that mines structured and unstructured EHR data to find trial candidates. Comparable to Trialmed's recruitment business and a leading technology-enabled disruptor to legacy recruitment approaches.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Acurian social profiles
Digital presenceAcurian financial estimates
Financial estimateRevenue estimate
Valuation estimate
Acurian leadership team
Management profileNumber of profiles
Profiles2 records
Acurian funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Acurian M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Acurian
What does Acurian do?
Acurian (operating as Trialmed) recruits patients and physicians for participation in clinical drug trials and delivers integrated clinical trial site services to pharmaceutical sponsors and CROs. The company operates a network of 250+ owned clinical trial sites across the US, UK, Czech Republic, and Poland, supported by a 20M+ identified patient database, and provides patient identification, engagement, pre-screening, site management, and home/remote trial visit services across multiple therapy areas.
Is Acurian a public or private company?
Acurian is a private company. It is classified as corporate owned and is currently operating.
When was Acurian founded?
Acurian was founded in 1998. It employs 51 to 100 people.
Where is Acurian based?
Acurian is headquartered in Horsham, United States, in the North America region.
How does Acurian make money?
One revenue line is on record: clinical trial site services.
Who are Acurian's main competitors?
Direct peers on record are Velocity Clinical Research, CenExel and Medpace. Broad incumbents are ICON plc, IQVIA, Syneos Health, PPD (Pharmaceutical Product Development) and Parexel. Emerging players are Science 37 and Deep 6 AI.
Does Acurian have an API?
No public API is recorded for Acurian.
What industry is Acurian in?
Acurian's product category is Clinical Trial Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 5417 and its SIC code is 8731.